Literature DB >> 16934340

Classification of hepatitis B virus genotypes by the PCR-Invader method with genotype-specific probes.

Kenichi Tadokoro1, Mariko Kobayashi, Toshikazu Yamaguchi, Fumitaka Suzuki, Saeko Miyauchi, Toru Egashira, Hiromitsu Kumada.   

Abstract

Hepatitis B virus is a worldwide public health problem. A simple and effective test to identify viral genotypes would greatly aid efforts to understand and control the spread of this disease. A serial invasive signal amplification reaction assay (PCR-Invader assay) was developed for distinguishing the known eight genotypes (A-H) and four subgenotypes (Aa, Ae, Ba, Bj) of hepatitis B virus (HBV). The preS/S and core regions were amplified by multiplex PCR and delivered to 12 wells containing genotype-specific Invader probes. By observing the fluorescence patterns in the wells, HBV sub/genotypes can be assigned. A total of 505 serum samples containing HBV/HBsAg in Japan was examined by PCR-Invader and compared the results with those from ELISA assays with monoclonal antibodies against epitopes on gene products of the preS2 region and with a genotype-specific probe assay (GSPA) based on the preS1 region. Genotypes determined by the PCR-Invader agreed with those of the ELISA method in 98.2% of cases and with the GSPA method in 97.1% of cases. Co-infection with two distinct genotypes was correctly identified by the PCR-Invader in four serum samples, as determined by GSPA. Thus, the PCR-Invader assay is a useful tool for detecting the 10 known HBV sub/genotypes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934340     DOI: 10.1016/j.jviromet.2006.07.014

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  15 in total

Review 1.  Antiviral therapies: focus on hepatitis B reverse transcriptase.

Authors:  Eleftherios Michailidis; Karen A Kirby; Atsuko Hachiya; Wangdon Yoo; Sun Pyo Hong; Soo-Ok Kim; William R Folk; Stefan G Sarafianos
Journal:  Int J Biochem Cell Biol       Date:  2012-04-16       Impact factor: 5.085

2.  Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan.

Authors:  Fumitaka Suzuki; Yasuji Arase; Yoshiyuki Suzuki; Norio Akuta; Hitomi Sezaki; Yuya Seko; Yusuke Kawamura; Tetsuya Hosaka; Masahiro Kobayashi; Satoshi Saito; Kenji Ikeda; Mariko Kobayashi; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2012-02-24       Impact factor: 7.527

3.  Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection.

Authors:  Nami Mori; Fumitaka Suzuki; Yusuke Kawamura; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Masahiro Kobayashi; Satoshi Saito; Yoshiyuki Suzuki; Yasuji Arase; Kenji Ikeda; Mariko Kobayashi; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2012-02-29       Impact factor: 7.527

4.  Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus.

Authors:  Mariko Kobayashi; Fumitaka Suzuki; Norio Akuta; Hitomi Sezaki; Yoshiyuki Suzuki; Tetsuya Hosaka; Yusuke Kawamura; Masahiro Kobayashi; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Kazuaki Chayama; Yuzo Miyakawa; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2012-03-23       Impact factor: 7.527

5.  Adenovirus-expressed preS2 antibody inhibits hepatitis B virus infection and hepatic carcinogenesis.

Authors:  Qian Zhang; Zhi-Qing Li; Hu Liu; Jia-He Yang
Journal:  World J Gastroenterol       Date:  2012-01-28       Impact factor: 5.742

6.  The PCR-invader method (structure-specific 5' nuclease-based method), a sensitive method for detecting EGFR gene mutations in lung cancer specimens; comparison with direct sequencing.

Authors:  Katsuhiko Naoki; Kenzo Soejima; Hiroaki Okamoto; Junko Hamamoto; Naoya Hida; Ichiro Nakachi; Hiroyuki Yasuda; Sohei Nakayama; Satoshi Yoda; Ryosuke Satomi; Shinnosuke Ikemura; Hideki Terai; Takashi Sato; Koshiro Watanabe
Journal:  Int J Clin Oncol       Date:  2011-02-11       Impact factor: 3.402

7.  A case of lamivudine-sensitive de novo acute hepatitis B induced by rituximab with the CHOP regimen for diffuse large B cell lymphoma.

Authors:  Toru Takahashi; Tadashi Koike; Shigeo Hashimoto; Tomofumi Miura; Junichiro Nakamura; Satoshi Yamada; Tsutomu Miura; Masahiko Yanagi; Kazuhide Yamazaki; Shogo Okoshi; Yutaka Aoyagi
Journal:  Hepatol Int       Date:  2008-09-23       Impact factor: 6.047

8.  Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs.

Authors:  Fumitaka Suzuki; Yoshiyuki Suzuki; Tetsuya Hosaka; Hitomi Sezaki; Norio Akuta; Shunichiro Fujiyama; Yusuke Kawamura; Masahiro Kobayashi; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Mariko Kobayashi; Rie Mineta; Yukiko Suzuki; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2016-10-03       Impact factor: 7.527

Review 9.  Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions.

Authors:  Mahmoud Reza Pourkarim; Samad Amini-Bavil-Olyaee; Fuat Kurbanov; Marc Van Ranst; Frank Tacke
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

10.  Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine.

Authors:  Fumitaka Suzuki; Tetsuya Hosaka; Yoshiyuki Suzuki; Norio Akuta; Hitomi Sezaki; Tasuku Hara; Yusuke Kawamura; Masahiro Kobayashi; Satoshi Saitoh; Yasuji Arase; Kenji Ikeda; Mariko Kobayashi; Sachiyo Watahiki; Rie Mineta; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2013-08-09       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.